Study of AZD3632 Monotherapy or in Combination with Anticancer Agents in Participants with Advanced Haematologic Malignancies with KMT2Ar, NPM1m, or other Genotypes Associated with HOX Overexpression.
Clinical Trial Grant
Awarded By
AstraZeneca AB
Start Date
December 22, 2025
End Date
December 23, 2030
Awarded By
AstraZeneca AB
Start Date
December 22, 2025
End Date
December 23, 2030